药学与治疗学委员会COVID-19应对计划
Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19.
作者信息
Abu Esba Laila Carolina, Al-Abdulkarim Hana Abdullah, Alrushidan Ahmed, Al Harbi Mohammed
机构信息
Clinical Pharmacist, Ministry of National Guard, Health Affairs, and Joint Appointment Lecturer of Pharmacy Practice at King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
出版信息
Glob J Qual Saf Healthc. 2020 May 19;3(2):55-64. doi: 10.36401/JQSH-20-9. eCollection 2020 May.
As the Pharmacy and Therapeutics (P&T) committee acts as an advisory committee on therapeutic options, it is important during pandemics, such as the current Coronavirus disease 2019 pandemic, to quickly search the evidence, be able to select the most appropriate therapies despite the limited evidence, and make appropriate decisions related to which drugs to procure and stock. Potential therapies and recommendations to the P&T committee at a large healthcare institution as means of a preparedness plan are reviewed here.
由于药学与治疗学（P&T）委员会充当治疗方案的咨询委员会，在大流行期间，如当前的2019年冠状病毒病大流行，迅速检索证据、尽管证据有限仍能够选择最合适的治疗方法以及就采购和储备哪些药物做出适当决策非常重要。本文回顾了作为准备计划手段向大型医疗机构的P&T委员会提出的潜在治疗方法和建议。
Zotero 插件